Recent News

• 03.12.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.06.2025 - Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.06.2025 - Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.05.2025 - Raymond James 46th Annual Institutional Investors Conference
• 02.27.2025 - Q4 2024 Pacira BioSciences, Inc. Earnings Conference Call
• 02.27.2025 - Pacira BioSciences Reports Fourth Quarter and Full-Year 2024 Financial Results
• 02.27.2025 - Pacira BioSciences Reports Fourth Quarter and Full-Year 2024 Financial Results
• 02.27.2025 - Pacira BioSciences Acquires Remaining Equity Stake of GQ Bio
• 02.27.2025 - Pacira BioSciences Acquires Remaining Equity Stake of GQ Bio
• 02.26.2025 - Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in March

Recent Filings

• 03.06.2025 - 144 Report of proposed sale of securities
• 02.27.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.27.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.27.2025 - EX-99.1 EX-99.1
• 02.27.2025 - 8-K Current report